• TRADE NAMES: Sevorane; Ultane (AbbVie)
  • INDICATIONS: Induction and maintenance of general anesthesia
  • CLASS: Anesthetic; inhalation
  • HALF-LIFE: 15–23 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Mivacurium

Please login to view the rest of this drug profile.

Page last updated 11/26/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric